This hypothesis is supported by evidence that USP13 stabilizes MCL-1 through deubiquitination to reduce mitochondrial apoptosis [100], and that downregulation of USP13 in cisplatin-induced AKI leads to increased MCL-1 degradation [80]. Here, MCL1 is linked to acute kidney injury.